DC, Maryland, Virginina pause Johnson and Johnson Vaccine pending investigation
The CDC and FDA made the recommendation in order to investigate reports of potentially dangerous blood clots.
WASHINGTON — Health departments in D.C., Maryland, and Virginia say they will no longer administer Johnson & Johnson COVID-19 vaccines following a recommended pause by the Centers for Disease Control and Prevention and the Food and Drug Administration.
The agencies recommended the pause Tuesday to investigate concerns of blood clots related to the single-dose vaccine.